RubrYc Therapeutics Overview
- Year Founded
-
2017
- Status
-
Acquired/Merged
- Employees
-
11
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$1M
RubrYc Therapeutics General Information
Description
Developer of novel biotherapeutic technologies designed to integrate chemistry and computation to discover and develop antibody-based drugs with epitope selectivity. The company's technologies decode protein interactions with the integration of data and biological science through molecular library synthesis, enabling bio-therapeutic partners to accelerate preclinical antibody discovery while minimizing the risks associated with current drug discovery paradigms.
Contact Information
Website
www.rubryc.comCorporate Office
- 733 Industrial Road
- San Carlos, CA 94070
- United States
Corporate Office
- 733 Industrial Road
- San Carlos, CA 94070
- United States
RubrYc Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Merger/Acquisition | 21-Sep-2022 | $1M | Completed | Generating Revenue | ||
| 4. Early Stage VC (Series A2) | 25-Apr-2021 | Completed | Generating Revenue | |||
| 3. Early Stage VC | 22-Jul-2019 | Completed | Pre-Clinical Trials | |||
| 2. Accelerator/Incubator | $10M | Completed | Pre-Clinical Trials | |||
| 1. Early Stage VC (Series A) | 09-Apr-2018 | $10M | $10M | Completed | Pre-Clinical Trials |
RubrYc Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-2 | ||||||||
| Series A | ||||||||
| Founders | 1,480,079 | $0.000100 | 8% | $0.71 | $0.71 | 1x | $0.71 | 3.3% |
RubrYc Therapeutics Comparisons
Industry
Financing
Details
RubrYc Therapeutics Competitors (1)
One of RubrYc Therapeutics’s competitors is Immune-Onc Therapeutics, a Venture Capital-Backed company based in Palo Alto, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Immune-Onc Therapeutics | Venture Capital-Backed | Palo Alto, CA |
RubrYc Therapeutics Patents
RubrYc Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2022119863-A1 | Generalized scaffolds for polypeptide display and uses thereof | Inactive | 01-Dec-2020 | ||
| WO-2022104009-A1 | Cd25 antibodies | Inactive | 13-Nov-2020 | ||
| WO-2020242766-A1 | Machine learning-based apparatus for engineering meso-scale peptides and methods and system for the same | Inactive | 31-May-2019 | ||
| JP-2022535769-A | Machine learning-based apparatus for manipulating mesoscale peptides and methods and systems therefor | Active | 31-May-2019 | ||
| WO-2020242765-A1 | Meso-scale engineered peptides and methods of selecting | Inactive | 31-May-2019 | G16B40/20 |
RubrYc Therapeutics Signals
RubrYc Therapeutics Former Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Boryung (United States) | PE/Buyout | Minority | ||
| MBC BioLabs | Accelerator/Incubator | Minority | ||
| Paladin Capital Group | Venture Capital | Minority | ||
| Third Point Ventures | Venture Capital | Minority | ||
| VC23 Investors | Venture Capital | Minority |
RubrYc Therapeutics FAQs
-
When was RubrYc Therapeutics founded?
RubrYc Therapeutics was founded in 2017.
-
Where is RubrYc Therapeutics headquartered?
RubrYc Therapeutics is headquartered in San Carlos, CA.
-
What is the size of RubrYc Therapeutics?
RubrYc Therapeutics has 11 total employees.
-
What industry is RubrYc Therapeutics in?
RubrYc Therapeutics’s primary industry is Drug Discovery.
-
Is RubrYc Therapeutics a private or public company?
RubrYc Therapeutics is a Private company.
-
What is the current valuation of RubrYc Therapeutics?
The current valuation of RubrYc Therapeutics is .
-
What is RubrYc Therapeutics’s current revenue?
The current revenue for RubrYc Therapeutics is .
-
How much funding has RubrYc Therapeutics raised over time?
RubrYc Therapeutics has raised $19.8M.
-
Who are RubrYc Therapeutics’s investors?
Boryung (United States), MBC BioLabs, Paladin Capital Group, Third Point Ventures, and VC23 Investors are 5 of 6 investors who have invested in RubrYc Therapeutics.
-
Who are RubrYc Therapeutics’s competitors?
Immune-Onc Therapeutics is a competitor of RubrYc Therapeutics.
-
When was RubrYc Therapeutics acquired?
RubrYc Therapeutics was acquired on 21-Sep-2022.
-
Who acquired RubrYc Therapeutics?
RubrYc Therapeutics was acquired by iBio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process